Supplemental Table 1. Factors associated with the primary composite outcome.
| Variables | Univariate analysis | ||
|---|---|---|---|
| HR | 95% CI | p-value | |
| Age, years | 1.06 | 1.04-1.09 | ＜0.0001 |
| Male | 0.80 | 0.46-1.39 | 0.43 |
| Body mass index, per 1 kg/m² | 0.94 | 0.88-1.01 | 0.08 |
| Hypertension | 0.97 | 0.61-1.54 | 0.90 |
| Diabetes mellitus | 1.71 | 1.08-2.71 | 0.02 |
| Current smoker | 0.89 | 0.57-1.41 | 0.63 |
| History of MI | 1.85 | 0.80-4.28 | 0.15 |
| With cancer | 0.60 | 0.15-2.44 | 0.47 |
| eGFR on admission, per 10 mL/min/1.73m² | 0.84 | 0.75-0.94 | 0.003 |
| HDL-C on admission, per 10 mg/dL | 0.92 | 0.76-1.09 | 0.36 |
| LDL-C on admission, per 10 mg/dL | 0.99 | 0.98-0.99 | 0.0007 |
| LDL-C after discharge (1 month), per 10 mg/dL (n = 335) | 0.90 | 0.80-1.01 | 0.08 |
| Reduction in LDL-C levels after discharge (1 month), per 10 mg/dL (n = 335) | 0.93 | 0.86-1.00 | 0.05 |
| TG on admission, per 10 mg/dL | 0.97 | 0.94-0.99 | 0.02 |
| BNP on admission, per 100 pg/mL | 1.13 | 1.07-1.19 | ＜0.0001 |
| hs-CRP ≥ 0.2 mg/dL on admission | 1.02 | 0.65-1.61 | 0.92 |
| hs-CRP ≥ 0.2 mg/dL in the chronic phase (n = 399) | 1.85 | 1.13-3.02 | 0.01 |
| GNRI ＜ 92 | 2.37 | 1.28-4.42 | 0.006 |
| LVEF on admission, per 10% | 0.70 | 0.57-0.85 | 0.0003 |
| STEMI | 1.42 | 0.82-2.47 | 0.22 |
| Multivessel disease | 1.59 | 1.01-2.51 | 0.04 |
| Medication at discharge | |||
| Beta blocker | 1.37 | 0.84-2.21 | 0.21 |
| ACE-I or ARB | 1.16 | 0.64-2.11 | 0.63 |
| Strong statin | 0.50 | 0.26-0.99 | 0.04 |
| Gait speed, per 0.1 m/s (344 patients) | 0.82 | 0.74-0.92 | 0.0006 |
| Ln RHI, per 0.1 | 0.78 | 0.71-0.86 | ＜0.0001 |
| Low LDL-C group | 2.66 | 1.66-4.26 | ＜0.0001 |
ACE-I, angiotensin-converting enzyme inhibitor; ARB, angiotensin II receptor blocker; BNP, B- type natriuretic peptide; eGFR, estimated glomerular filtration rate; GNRI, geriatric nutritional risk index; HDL-C, high-density lipoprotein cholesterol; hs-CRP, high-sensitivity C-reactive protein; LDL-C, low-density lipoprotein cholesterol; Ln RHI, logarithmic value of reactive hyperemia index; LVEF, left ventricular ejection fraction; MI, myocardial infarction; STEMI, ST-segment elevation myocardial infarction; TG, triglycerides.